Understanding the evidence used in drug product withdrawals
European Pharmaceutical Review
DECEMBER 14, 2023
Observational studies should not be seen as competition to RCTs but as complementary to them, and as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health. EMA/95098/2010. 2018; 8(1). Internet] European Medicines Agency.
Let's personalize your content